BioCatalyst

TOL2506, Tamoxifen, Letrozole Tablets, Anastrozole Tablets — catalyst calendar

1 verified catalyst event(s) referencing TOL2506, Tamoxifen, Letrozole Tablets, Anastrozole Tablets, each linked to its official source. Verified as of 2026-09-30.

Upcoming

DateEventCompanyDrugOfficial source & verification
2026-11-30
in 2mo
ESTIMATED
 READOUT
Ovarian Suppression Evaluating Subcutaneous Leuprolide Acetate in Breast Cancer
Phase 3 · Breast Cancer
 Tolmar Inc. TOL2506, Tamoxifen, Letrozole Tablets, A ClinicalTrials.gov ↗
✓ Source-checked 2026-09-30
Sponsor-projected date — can change
Disclaimer. Bio Catalyst Calendar is a public-events data calendar. Every date is sourced and linked to an official record (ClinicalTrials.gov, FDA / Federal Register, openFDA). It is scheduling and reference data only — NOT investment advice, a recommendation, or a buy/sell signal. Dates set by sponsors and the FDA can change; always confirm against the linked official source.